Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03858075 · ClinicalTrials.gov registry record · Phase 1
Safety, Tolerability, Pharmacokinetics, and Food Effect of BLU-782 in Healthy Adults
A Phase 1 study, sponsored by Blueprint Medicines Corporation.
- Completed
- Registry status
- Phase 1
- Development phase
- 108
- Enrollment target
NCT03858075 is a Phase 1 study that has completed, run by Blueprint Medicines Corporation. The registered enrollment target is 108 participants.
The verdict
NCT03858075, a Phase 1 study, has completed, sponsored by Blueprint Medicines Corporation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 108 participants
- Enrollment target
Study Summary
The main objectives of this study are to assess the safety, tolerability, pharmacokinetics (PK), and food effect of BLU-782 in healthy adult subjects.
Interventions
- DRUG Placebo
- DRUG BLU-782
- DRUG BLU-782 taken with food
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2019-02-12 |
| Est. Completion | 2019-09-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03858075
The ClinicalTrials.gov registry entry for NCT03858075 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Blueprint Medicines Corporation, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT03858075 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03858075 about?
NCT03858075 is a clinical study titled "Safety, Tolerability, Pharmacokinetics, and Food Effect of BLU-782 in Healthy Adults". The main objectives of this study are to assess the safety, tolerability, pharmacokinetics (PK), and food effect of BLU-782 in healthy adult subjects.
What is the current status of trial NCT03858075?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 108 participants. The study started on 2019-02-12. Estimated completion is 2019-09-11.
What interventions are being tested in trial NCT03858075?
The interventions under investigation include: Placebo (DRUG), BLU-782 (DRUG), BLU-782 taken with food (DRUG).
Who is sponsoring clinical trial NCT03858075?
This trial is sponsored by Blueprint Medicines Corporation, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.